Novo Nordisk, Ozempic
Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on September 2 and set a price ...
Novo Nordisk A/S is likely to contribute about half of Denmark’s economic expansion this year, helping the nation to ...
Eli Lilly and Novo Nordisk compete in a handful of different markets. Novo Nordisk is scaling up its output and ...
Novo Nordisk’s Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a ...
After a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for its obesity star Wegovy ...
All doses of Novo Nordisk’s Ozempic are expected to face “intermittent shortages” in Europe during the fourth quarter of the ...
Upcoming results from a bunch of clinical trials could extend the rally stocks have already been enjoying the past few years.
UAE’s Ministry of Health and Prevention (MoHAP) has teamed up with Novo Nordisk Pharma Gulf, a major player in global healthcare, to create a national scientific guide to tackle obesity and manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results